These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

175 related items for PubMed ID: 121579

  • 1. [T and B-lymphocytes in acute lymphoblastic leukemia of childhood at diagnosis and during the initial stages of therapy (author's transl)].
    De Martino M, Biagioli EC, Pisanu C, Lippi A, Novembre E, Guazzelli C, Vierucci A.
    Haematologica; 1979 Aug; 64(4):442-54. PubMed ID: 121579
    [No Abstract] [Full Text] [Related]

  • 2. [Surface markers of T and B lymphocytes: II. Their investigation in 13 patients with untreated acute lymphoblastic leukaemia (ALL) (author's transl)].
    Tomić BL.
    Lijec Vjesn; 1980 Dec; 102(12):689-93. PubMed ID: 7022076
    [No Abstract] [Full Text] [Related]

  • 3. [Surface markers of T and B lymphocytes: I. General view and acute lymphoblastic leukaemia (ALL) (author's transl)].
    Tomić BL.
    Lijec Vjesn; 1980 Nov; 102(11):643-6. PubMed ID: 7024694
    [No Abstract] [Full Text] [Related]

  • 4. [Immunological classification of acute lymphoblastic leukemias (author's transl)].
    Tubiana N, Derre M, Carcassonne Y.
    Sem Hop; 1980 Nov; 56(47-68):1993-7. PubMed ID: 6256912
    [Abstract] [Full Text] [Related]

  • 5. [Cytochemical characteristics and immunologic markers in acute lymphoblastic leukemias (author's transl)].
    Dorlhiac P, Genter G, Jamra M.
    Sangre (Barc); 1981 Nov; 26(4):433-8. PubMed ID: 6974901
    [No Abstract] [Full Text] [Related]

  • 6. [The significance of "T" and "B" markers on peripheral blood lymphocytes by leukemias (author's transl)].
    Handl S, Gabrilovac J, Milić N, Boranić M, Veselić B, Bauer Z, Koprcina M.
    Lijec Vjesn; 1978 Jan; 100(1):11-6. PubMed ID: 306016
    [No Abstract] [Full Text] [Related]

  • 7. [Immunological characterization of human chronic lymphatic leukaemia (author's transl)].
    Barboni F, Rovinetti C, Lombardo M, Beltrandi E, Di Marzio A, Tabacchi P, Di Primio R, Geraci L, Battista P, Torlontano G.
    Haematologica; 1979 Apr; 64(2):159-72. PubMed ID: 112007
    [No Abstract] [Full Text] [Related]

  • 8. [T and B lymphocytes before, during, and after cytostatic therapy of acute lymphoblastic leukemia (ALL) in children (author's transl)].
    Wehinger H, Karitzky D.
    Klin Padiatr; 1977 May; 189(3):234-41. PubMed ID: 301585
    [Abstract] [Full Text] [Related]

  • 9. [The heterogeneity of human lymphoid leukemias unmasked by immunological studies of membrane markers (author's transl)].
    Seligmann M, Brouet JC, Preud'homme JL.
    Nouv Rev Fr Hematol Blood Cells; 1977 May; 18(2):339-50. PubMed ID: 303356
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. [Disease- and therapy-related immunodefects in acute lymphoblastic leukemia (a.l.l.) (author's transl)].
    Eife R.
    Klin Padiatr; 1978 Jan; 190(1):28-43. PubMed ID: 305501
    [No Abstract] [Full Text] [Related]

  • 12. [Surface nature of B and T cell in chronic lymphocytic leukemia and allied disorders (author's transl)].
    Kinoshita K, Kamihira S, Ichimaru M.
    Rinsho Ketsueki; 1976 Apr; 17(4):428-35. PubMed ID: 1085378
    [No Abstract] [Full Text] [Related]

  • 13. [Effect of central nervous system irradiation in children with lymphoblastic leukemia on lymphocyte subpopulations and leukocyte migration inhibition indicators in the peripheral blood].
    Cesarz-Kruz E, Lukas A, Sroczyńska M, Lukas W, Sońta-Jakimczyk D.
    Pediatr Pol; 1981 Sep; 56(9):1003-7. PubMed ID: 6976551
    [No Abstract] [Full Text] [Related]

  • 14. [Immunologic types of lymphocytes in acute lymphatic leukemia during remission (author's transl)].
    Winterleitner H, Palencia C, Knapp W, Eibl M, Krepler P.
    Padiatr Padol; 1975 Sep; 10(3):237-43. PubMed ID: 1081665
    [Abstract] [Full Text] [Related]

  • 15. Immunological and molecular classification of acute lymphoblastic leukemia.
    Foa R, Migone N, Gavosto F.
    Haematologica; 1986 Sep; 71(4):277-85. PubMed ID: 3096821
    [No Abstract] [Full Text] [Related]

  • 16. The study of T-, B-, O- lymphocytes in acute lymphoblastic leukemia.
    Bogusławska-Jaworska J, Chybicka A.
    Arch Immunol Ther Exp (Warsz); 1978 Sep; 26(1-6):859-66. PubMed ID: 312091
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Definition of the high-risk acute lymphoblastic leukemia patient by immunological phenotyping with monoclonal antibodies.
    Zipf TF, Fox RI, Dilley J, Levy R.
    Cancer Res; 1981 Nov; 41(11 Pt 2):4786-9. PubMed ID: 6975160
    [Abstract] [Full Text] [Related]

  • 19. The evaluation of prognostic value of immunological markers in acute lymphoblastic leukemia (ALL) after intensification of treatment schedule.
    Bogusławska-Jaworska J, Rodziewicz B.
    Arch Immunol Ther Exp (Warsz); 1986 Nov; 34(4):392-5. PubMed ID: 3492185
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.